Arcturus Therapeutics Ownership | Who Owns Arcturus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Arcturus Therapeutics Ownership Summary

Arcturus Therapeutics is owned by 97.02% institutional investors, 8.46% insiders. Federated hermes is the largest institutional shareholder, holding 17.41% of ARCT shares. Federated Hermes Kaufmann R is the top mutual fund, with 9.01% of its assets in Arcturus Therapeutics shares.

ARCT Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Arcturus Therapeutics	97.02%	8.46%	-5.48%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Federated hermes	4.69M	17.41%	$114.30M
Blackrock	2.65M	9.83%	$64.52M
Ark investment management	1.96M	7.29%	$47.85M
Sumitomo mitsui trust	1.56M	5.80%	$38.06M
Nikko asset management americas	1.56M	5.80%	$37.97M
State street	1.52M	5.65%	$37.11M
Vanguard group	1.38M	5.13%	$33.72M
Dimensional fund advisors lp	918.22K	3.40%	$22.36M
Morgan stanley	795.94K	2.95%	$19.38M
Woodline partners lp	754.02K	2.80%	$18.36M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Portolan capital management	484.91K	0.97%	$11.81M
Nikko asset management americas	1.56M	0.44%	$37.97M
Diametric capital, lp	32.77K	0.43%	$797.83K
Ark investment management	1.96M	0.42%	$47.85M
Granahan investment management	344.55K	0.34%	$8.39M
Federated hermes	4.69M	0.27%	$114.30M
Belmont capital	40.00K	0.18%	$974.00K
Woodline partners lp	754.02K	0.18%	$18.36M
Harbor capital advisors	65.67K	0.12%	$1.60M
Gsa capital partners llp	61.63K	0.10%	$1.50M

Top Buyers

Holder	Shares	% Assets	Change
Millennium management	555.02K	0.01%	396.50K
Sumitomo mitsui trust	1.56M	0.03%	286.55K
Nikko asset management americas	1.56M	0.44%	286.55K
Ark investment management	1.96M	0.42%	275.31K
Portolan capital management	484.91K	0.97%	240.25K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-450.00K
State street	1.52M	0.00%	-436.10K
Point72 asset management	-	-	-244.15K
Great lakes advisors	-	-	-210.39K
Dimensional fund advisors lp	918.22K	0.01%	-185.60K

New Positions

Holder	Shares	% Assets	Change	Value
Allianz asset management gmbh	180.12K	0.01%	180.12K	$4.39M
Baker bros. advisors lp	151.33K	0.05%	151.33K	$3.68M
Gsa capital partners llp	61.63K	0.10%	61.63K	$1.50M
Vontobel	30.72K	0.00%	30.72K	$748.13K
Xtx topco	24.48K	0.05%	24.48K	$596.11K

Sold Out

Holder	Change
Financial gravity asset management	-1.00
Nelson, van denburg & campbell wealth management group	-5.00
Parallel advisors	-6.00
Innealta capital	-24.00
Bell investment advisors	-38.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	170	-3.95%	26,254,877	-0.08%	97	1.02%	81	6.58%	49	-27.94%
Jun 30, 2024	177	-6.35%	26,275,002	-3.49%	97	0.95%	76	-16.48%	68	11.48%
Mar 31, 2024	189	9.25%	27,224,704	7.13%	101	1.11%	91	-	61	15.09%
Dec 31, 2023	173	11.61%	25,412,469	1.02%	95	1.06%	91	26.39%	53	-1.85%
Sep 30, 2023	155	4.73%	25,156,306	6.49%	94	1.20%	72	-1.37%	54	3.85%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Federated Hermes Kaufmann R	2.44M	9.01%	-
Federated Hermes Kaufmann Growth	2.44M	9.01%	-
Federated Hermes Kaufmann Small Cap Grow	2.20M	8.13%	-
Federated Hermes Kaufmann Small Cap A	2.20M	8.13%	-
ARK Genomic Revolution	2.09M	7.72%	144.38K
ARK Genomic Revolution ETF	2.08M	7.70%	10.03K
Nikko AM ARK Pstv Chg Innovt P JPY Acc	2.04M	7.53%	-35.03K
Vanguard Total Stock Mkt Idx Inv	724.72K	2.68%	1.08K
SPDR® S&P Biotech ETF	719.28K	2.66%	7.95K
iShares Russell 2000 ETF	593.78K	2.19%	-1.33K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 15, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$249.12K
Jun 12, 2024	SASSINE ANDY	Chief Financial Officer	Sell	$1.60M
Jun 05, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$5.13K
Jun 03, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$1.04M
Mar 25, 2024	Chivukula Pad	Chief Scientific Officer & COO	Sell	$610.57K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	1
2024 Q2	-	3
2024 Q1	-	2
2023 Q4	-	2
2023 Q3	-	5

ARCT Ownership FAQ

Who Owns Arcturus Therapeutics?

Arcturus Therapeutics shareholders are primarily institutional investors at 97.02%, followed by 8.46% insiders and -5.48% retail investors. The average institutional ownership in Arcturus Therapeutics's industry, Biotech Stocks , is 47.04%, which Arcturus Therapeutics exceeds.

Who owns the most shares of Arcturus Therapeutics?

Arcturus Therapeutics’s largest shareholders are Federated hermes (4.69M shares, 17.41%), Blackrock (2.65M shares, 9.83%), and Ark investment management (1.96M shares, 7.29%). Together, they hold 34.52% of Arcturus Therapeutics’s total shares outstanding.

Does Blackrock own Arcturus Therapeutics?

Yes, BlackRock owns 9.83% of Arcturus Therapeutics, totaling 2.65M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 64.52M$. In the last quarter, BlackRock decreased its holdings by -93.164K shares, a -3.40% change.

Who is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested?

Portolan capital management is Arcturus Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.97% of its assets in 484.91K Arcturus Therapeutics shares, valued at 11.81M$.

Who is the top mutual fund holder of Arcturus Therapeutics shares?

Federated Hermes Kaufmann R is the top mutual fund holder of Arcturus Therapeutics shares, with 9.01% of its total shares outstanding invested in 2.44M Arcturus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools